Journal of Liver Cancer

Search: J Liver Cancer Search

CLOSE

Review Article

September 30, 2019

Liver Transplantation in Mixed Hepatocellular Carcinoma and Cholangiocarcinoma

Jong Man Kim

J Korean Liver Cancer Stud. 2019;19(2):85-90.

Mixed hepatocellular carcinoma and cholangiocarcinoma (HCC-CC) are rare tumors, and the risk factors associated with them are not well understood yet. Moreover, the diagnosis of mixed HCC-CC can be complicated...

Review Article

September 30, 2019

Contrast-enhanced Ultrasonography: The Third Modality for Differentiation of Liver Mass

Min Kyu Kang, Moon Young Kim, Seong Hee Kang, et al.

J Korean Liver Cancer Stud. 2019;19(2):91-96.

Contrast-enhanced ultrasonography (CEUS) using microbubble ultrasonography contrast agent can show the vascular structure and unique contrast enhancement patterns of focal liver lesions, including hepatocellular carcinoma (HCC). CEUS shows three phases,...

Review Article

September 30, 2019

The Genomic Landscape and Its Clinical Implications in Hepatocellular Carcinoma

Sun Young Yim, Ju-Seog Lee

J Korean Liver Cancer Stud. 2019;19(2):97-107.

The pathogenesis of hepatocellular carcinoma (HCC) is a complex process. During the last decade, advances in genomic technologies enabled delineation of the genomic landscape of HCC, resulting in the identification...

Original Article

September 30, 2019

Serum PD-1 Levels Change with Immunotherapy Response but Do Not Predict Prognosis in Patients with Hepatocellular Carcinoma

Hye Won Lee, Kyung Joo Cho, Soon Young Shin, et al.

J Korean Liver Cancer Stud. 2019;19(2):108-116.

Background/Aims: Programmed death receptor 1 (PD-1) is a promising new target for treatment of patients with hepatocellular carcinoma (HCC). A high expression level of programmed death-ligand 1 (PD-L1) is a...

Original Article

September 30, 2019

An Analysis for Survival Predictors for Patients with Hepatocellular Carcinoma Who Failed to Sorafenib Treatment in Pre-regorafenib Era

Chan Uk Lee, Young-Sun Lee, Ji Hoon Kim, et al.

J Korean Liver Cancer Stud. 2019;19(2):117-127.

Background/Aims: Sorafenib is the standard treatment for patients with advanced hepatocellular carcinoma (HCC). We aimed to investigate the prognosis predictors and the role of second-line cytotoxic systemic chemotherapy (CSC) in...

Original Article

September 30, 2019

Tenofovir and Entecavir Have Similar Renal Adverse Events on Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization

Young Youn Cho, Young Hwan Choi, Su Jong Yu, et al.

J Korean Liver Cancer Stud. 2019;19(2):128-135.

Background/Aims: Tenofovir disoproxil fumarate (TDF) is potentially nephrotoxic in chronic hepatitis B patients. Hepatocellular carcinoma (HCC) patients treated using transarterial chemoembolization (TACE) are at an increased risk of renal injury....

Current Issue: Volume 19(2); Sep 2019

The General Rules for the Study of Primary Liver Cancer Jae Young Jang, June Sung Lee, Hyung-Joon Kim, et al. J Liver Cancer. 2017;17(1):19-44. Review Article March 31, 2017 Cited By 5 PDF	Hepatocellular Carcinoma Prediction Models for Patients with Chronic Hepatitis B Virus Infection in the Era of Potent Antiviral Therapy Lee, Hye Won , Kim, Beom Kyung J Liver Cancer. 2018;18(2):87-93. Review Article September 30, 2018 Cited By 2 PDF
Cause of Mortality for Hepatocellular Carcinoma Patients who were Diagnosed within the Milan Criteria Hyun-Woo Lee, Dong Hyun Sinn, Wonseok Kang, et al. J Liver Cancer. 2016;16(2):101-107. Original Article September 30, 2016 Cited By 2 PDF	Transarterial Chemolipiodolization for Hepatocellular Carcinoma with Central Bile Duct Invasion Causing Conjugated Hyperbilirubinemia: Safety and Prognostic Factors for Survival Yang, Keungmo , Sung, Pil Soo , Oh, Jung Suk , et al. J Liver Cancer. 2018;18(2):121-129. Original Article September 30, 2018 Cited By 1 PDF
Multicenter Planning Comparison of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis (KROG 16-17) Bae, Sun Hyun , Kim, Mi Sook , Jang, Won Il , et al. J Liver Cancer. 2018;18(2):130-141. Original Article September 30, 2018 Cited By 1 PDF	Systemic Therapy for Advanced Hepatocellular Carcinoma: Targeted Therapy and Immunotherapy Kim, Bo Hyun , Park, Joong Won J Liver Cancer. 2018;18(1):17-22. Review Article March 31, 2018 Cited By 1 PDF
Incidence of Primary Liver Cancer in Subjects with Chronic Hepatitis B in Korean National Liver Cancer Screening Program In Seung Choi, Chi Hyuck Oh, So Young Park, et al. J Liver Cancer. 2017;17(2):136-143. Original Article September 30, 2017 Cited By 1 PDF	Sarcomatoid Intrahepatic Cholangiocarcinoma: A Rare Case of Primary Liver Cancer Doo Hyuck Lee, Kyu Hyung Han, Sun Young Ahn, et al. J Liver Cancer. 2016;16(2):139-144. Case Report September 30, 2016 Cited By 1 PDF

Editorial Office: 1527 Gangnam Finance Plaza (FASTFIVE), 419 Teheran-ro, Gangnam-gu, Seoul 06160, Korea
Tel: +82-2-313-1900 E-mail: liver@klcsg.or.kr